MedTrace Logo

Clinical Audit of GI Endoscopic Complications in a Tertiary Care Hospital

NCT05228353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42471

Last updated 2023-09-14

No results posted yet for this study

Summary

Endoscopy of the upper gastrointestinal tract using fiberoptic endoscopes was introduced in the late 1950s and provided the first opportunity for direct visualization of the esophagus, stomach, and duodenum and colon in vivo. GI Endoscopy is usually considered a safe and effective procedure. However complications do exist and procedure related costs are significant. There is a lack of prospective studies on complications of diagnostic and therapeutic endoscopic procedures.There is a lack of prospective studies on complications of diagnostic and therapeutic endoscopic procedures. Knowledge of potential endoscopic adverse events, their expected frequency, and the risk factors for their occurrence may help to minimize the incidence of adverse events. Review of adverse events as part of a continuing quality improvement process may serve to educate endoscopists, help to reduce the risk of future adverse events, and improve the overall quality of endoscopy.

Conditions

  • Endoscopy
  • Complication

Sponsors & Collaborators

  • Asian Institute of Gastroenterology, India

    lead OTHER

Principal Investigators

  • Inavolu Pradev, MBBS, MD, DM · Consultant

  • Hardik Rughwani, MBBS, MD, DM · Consultant

  • Mohan ramchandani, MBBS, MD, DM · Consultant

  • Nageshwar D Reddy, MBBS, MD, DM · Chief

  • Anudeep KV, MBBS, MD, DM · Consultant

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05228353 on ClinicalTrials.gov